Recruiting NCT06793397
This study is recruiting in the United States, in Australia, in the United Kingdom, .... It is testing a Deuterated Psilocin Analog for depression.
Multiple locations, including Birmingham Depression Behavioral From 18 Years to 85 Years
Countries United States, Australia, United Kingdom, ...
Sponsor Cybin IRL Limited
Condition Depression Recruiting NCT07218250
This study is recruiting in the United States. It is testing a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress for depression.
Multiple locations, including Basking Ridge Anxiety, Depression Behavioral Over 18 Years
Countries United States
Sponsor Memorial Sloan Kettering Cancer Center
Condition Anxiety, Depression Recruiting NCT07186309
This study is recruiting in the United States. It is testing a Test for depression.
In Charlottesville Depression Device i A study involving a tool, app, wearable, test, or medical device. Over 18 Years
Countries United States
Sponsor University of Virginia
Condition Depression Recruiting ISRCTN16011638
This study is recruiting in China. It is testing a traditional Chinese herbal formula combined with standard medication for Depression.
In China Depression Other From 18 Years to 70 Years
Countries China
Sponsor Beijing Municipal Health Commission
Condition Depression Recruiting NCT03423680
This study is recruiting in South Korea. It is testing abilify® Tablet(Aripiprazole) for depression in bipolarity.
In Seoul Bipolarity, Depression Drug i A study involving a medication or substance. From 19 Years to 70 Years
Countries South Korea
Sponsor Korea Otsuka Pharmaceutical Co., Ltd.
Condition Bipolarity, Depression Recruiting NCT07412756
This study is recruiting in the United States, in Australia, in Canada, .... It is testing brenipatide for depression.
Multiple locations, including Moorpark Depression Drug From 18 Years to 75 Years
Countries United States, Australia, Canada, ...
Sponsor Eli Lilly and Company
Condition Depression Recruiting NCT07053345
This study is recruiting in South Korea. It is testing esketamine Nasal Spray for depression.
Multiple locations, including Goyang Si Gyeonggi Do Depression Drug From 18 Years to 64 Years
Countries South Korea
Sponsor Janssen Korea, Ltd., Korea
Condition Depression Recruiting ISRCTN81388388
This study is recruiting in the United Kingdom. It is testing home-use brain stimulation to treat Depression for depression in bipolarity.
In United Kingdom Bipolarity, Depression Other From 18 Years to 110 Years
Countries United Kingdom
Sponsor King's College London
Condition Bipolarity, Depression Recruiting NCT05803551
This study is recruiting in the United States. It focuses on Depression.
In Jacksonville Depression Drug From 18 Years to 99 Years
Countries United States
Sponsor Mayo Clinic
Condition Depression Recruiting NCT05599126
This study is recruiting in China. It is testing mianserin for depression.
In Shanghai Depression Drug From 18 Years to 60 Years
Countries China
Sponsor Zhenghui YI
Condition Depression Recruiting ISRCTN16493616
This study is recruiting in the United Kingdom. It is testing resilience training for Depression.
In United Kingdom Depression Other From 18 Years to 120 Years
Countries United Kingdom
Sponsor University of Oxford
Condition Depression Recruiting NCT07573176
This study is recruiting in the United States. It is testing seltorexant for depression.
Multiple locations, including Walnut Creek Depression Drug From 18 Years to 74 Years
Countries United States
Sponsor Janssen Research & Development, LLC
Condition Depression